HOME >> MEDICINE >> NEWS
Fred Hutchinson Research Center awarded $7 million grant

WHITE PLAINS, N.Y. (October 2, 2002) - The Leukemia & Lymphoma Society (the Society) announced it has awarded a $7 million grant through its Specialized Center of Research (SCOR) program to Dr. Irwin Bernstein, head of pediatric oncology research at the Fred Hutchinson Cancer Research Center in Seattle. Dr. Bernstein will accept the award in Washington, D.C. at the Society's Journey of Hope Research Award Dinner tomorrow night. The dinner will to be hosted by ABC News veteran Sam Donaldson.

SCOR is the Society's most ambitious research program and one of the largest coordinated efforts to combat leukemia, lymphoma, myeloma and Hodgkin's disease with funding that rivals federal support for blood cancers. Through SCOR grants, teams of researchers representing different disciplines focus on improving the treatment and diagnosis of blood cancers.

The research initiative, conducted by Dr. Bernstein and a team of internationally recognized researchers, is aimed at developing less toxic and more effective immune-based therapies for treating advanced leukemia and lymphoma. The researchers will attempt to harness immune cells and antibodies to selectively kill cancerous cells. In addition to Dr. Bernstein, who pioneered monoclonal antibody therapy for leukemia as well as the development, with Wyeth-Ayerst, of a monoclonal drug conjugate known as Mylotarg, the research team includes scientists from Fred Hutchinson and the University of Washington Academic Medical Center: Dr. Rainer Storb, head of transplantation biology at Fred Hutchinson and pioneer of non-myeloablative stem-cell transplantation (mini transplants) also one of the researchers who developed bone-marrow transplantation. Drs. Philip Greenberg, head of immunology at Fred Hutchinson, and Stanley Riddell, discoverers of a technique known as Rapid Expansion Method (REM), the technology used to expand antigen-specific T cells for use in adoptive immunotherapy techniques. Dr. Oliver Press, int
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
2-Oct-2002


Page: 1 2 3

Related medicine news :

1. Fred Hutchinson receives $9.7 million to lead early detection consortium
2. Fred Hutchinson uses IBM technology to help find genetic links to immune-system diseases
3. Fred Hutchinson Cancer Research Center study shows retinoids kill childhood brain tumor cells
4. Fred Hutchinson oversees two grants of nearly $8 million to develop blood test for breast cancer
5. Fred Hutchinson receives $12.7 million to lead prostate-cancer consortium
6. Hutchinson Center receives $1.2 million from National Science Foundation to study plant genetics
7. Of vasectomies, vitamins and prostate-cancer risk: Hutchinson Center study examines the links
8. Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV
9. Researchers search for first sign of congestive heart failure
10. Research offers hope of new treatments for liver damage
11. Research suggests possible blood test for multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... ... June 27, 2017 , ... Harbour , a DAO (decentralized ... the Ethereum blockchain, has released their technical specifications . , 2017 has seen ... little systematic approach for determining which offerings will garner the greatest ROI. Dean Eigenmann, ...
(Date:6/27/2017)... NY (PRWEB) , ... June 27, 2017 , ... From ... members. The three-day event was held in Syracuse, New York, where EarQ is headquartered. ... changing industry, how to connect with today’s savvy consumer, and the latest in ...
(Date:6/27/2017)... ... June 27, 2017 , ... PR News is looking for ... guidebook. This guidebook offers an excellent branding and exposure opportunity for the author ... and how-to’s that fall into the following categories:, ,     Media ...
(Date:6/27/2017)... ... June 27, 2017 , ... Hammer Strength, the world’s leading performance ... Javair Gillett of the Houston Rockets the NBSCA Strength & Conditioning Coach of the ... by NBSCA members who vote to select the coach who embodies the highest level ...
Breaking Medicine News(10 mins):
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/24/2017)... , May 24, 2017  ivWatch LLC ... Equipment Manufacturer (OEM) Board to enable seamless integration ... patient monitoring systems, infusion pumps and other devices. ... will be able to help health care customers ... reduced risks related to IV therapy. ...
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
Breaking Medicine Technology:
Cached News: